Development of an alveolar chip model to mimic respiratory conditions due to fine particulate matter exposure
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Inhalation and Respiratory Drug Delivery · Air Quality Monitoring and Forecasting · Air Quality and Health Impacts
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study10.1016/S2542-5196(18)30028-7 ↗
2. Particulate-matter related respiratory diseases10.4046/trd.2019.0025 ↗
3. Loss of life expectancy from air pollution compared to other risk factors: a worldwide perspective10.1093/cvr/cvaa025 ↗
4. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action10.1016/S0140-6736(16)31597-5 ↗
5. Toxicity research of PM2.5 compositions in vitro10.3390/ijerph14030232 ↗
6. In vitro and in vivo experimental studies of PM2.5 on disease progression10.3390/ijerph15071380 ↗
7. Novel evidence for a greater burden of ambient air pollution on cardiovascular disease10.3324/haematol.2019.225086 ↗
8. Air pollution and cardiovascular disease: car sick
9. New approach methods to evaluate health risks of air pollutants: critical design considerations for in vitro exposure testing10.3390/ijerph17062124 ↗
10. Particulate air pollution: major research methods and applications in animal models10.4103/ed.ed_16_18 ↗
11. In vitro Alternatives to acute inhalation toxicity studies in animal models-a perspective10.3389/fbioe.2020.00549 ↗
12. Is it time for reviewer 3 to request human organ chip experiments instead of animal validation studies?10.1002/advs.202002030 ↗
13. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?10.1016/j.jacbts.2019.10.008 ↗
14. Organs-on-chips: into the next decade10.1038/s41573-020-0079-3 ↗
15. Robotic fluidic coupling and interrogation of multiple vascularized organ chips10.1038/s41551-019-0497-x ↗
16. Lung-on-a-chip: the future of respiratory disease models and pharmacological studies10.1080/07388551.2019.1710458 ↗
17. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro10.1038/nmeth.3697 ↗
18. A microengineered airway lung chip models key features of viral-induced exacerbation of asthma10.1165/rcmb.2020-0010MA ↗
19. Reconstituting organ-level lung functions on a chip10.1126/science.1188302 ↗
20. Matched-comparative modeling of normal and diseased human airway responses using a microengineered breathing lung chip10.1016/j.cels.2016.10.003 ↗
21. Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics10.1002/cpt.742 ↗
22. Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium10.1021/nn505399e ↗
23. Use of porous membranes in tissue barrier and co-culture models10.1039/C7LC01248A ↗
24. Stable chemical bonding of porous membranes and poly (dimethylsiloxane) devices for long-term cell culture10.1063/1.4883075 ↗
25. Organ-on-a-chip: recent breakthroughs and future prospects10.1186/s12938-020-0752-0 ↗
26. Organ-on-a-chip: opportunities for assessing the toxicity of particulate matter10.3389/fbioe.2020.00519 ↗
27. An estimation of mechanical stress on alveolar walls during repetitive alveolar reopening and closure10.1152/japplphysiol.00112.2015 ↗
28. Primary human lung alveolus-on-a-chip model of intravascular thrombosis for assessment of therapeutics10.1002/cpt.742 ↗
29. Emerging encapsulation technologies for long-term reliability of microfabricated implantable devices10.3390/mi10080508 ↗
30. Air-liquid interface: relevant in vitro models for investigating air pollutant-induced pulmonary toxicity10.1093/toxsci/kfy053 ↗
31. 3D alveolar in vitro model based on epithelialized biomimetically curved culture membranes10.1016/j.biomaterials.2020.120436 ↗
32. Dynamics of coarse and fine particle exposure in transport microenvironments10.1038/s41612-018-0023-y ↗
33. Direct and indirect effects of particulate matter on the cardiovascular system10.1016/j.toxlet.2011.11.008 ↗
34. The impact of PM2.5 on the human respiratory system
35. Diesel exhaust particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial barrier10.1111/cea.12597 ↗
36. Air pollutant-mediated disruption of sinonasal epithelial cell barrier function is reversed by activation of the Nrf2 pathway10.1016/j.jaci.2016.06.027 ↗
37. In vitro evaluation of organic extractable matter from ambient PM2.5 using human bronchial epithelial BEAS-2B cells: cytotoxicity, oxidative stress, pro-inflammatory response, genotoxicity, and cell cycle deregulation10.1016/j.envres.2019.01.052 ↗
38. Air-liquid interface exposure of lung epithelial cells to low doses of nanoparticles to assess pulmonary adverse effects10.3390/nano11010065 ↗
39. Source apportionment of fine-particle, water-soluble organic nitrogen and its association with the inflammatory potential of lung epithelial cells10.1021/acs.est.9b02523 ↗
40. Particle characterization and toxicity in C57BL/6 mice following instillation of five different diesel exhaust particles designed to differ in physicochemical properties10.1186/s12989-020-00369-9 ↗
41. Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing10.1039/C9LC00253G ↗
42. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips10.1038/s41551-019-0498-9 ↗
43. Organs-on-chips: into the next decade10.1038/s41573-020-0079-3 ↗
44. High-throughput tumor-on-a-chip platform to study tumor-stroma interactions and drug pharmacokinetics10.1002/adhm.202000880 ↗
45. Assessment of hospitalization and mortality from exposure to PM10 using AirQ modeling in Ilam, Iran10.1007/s11356-017-9794-7 ↗
46. Formation of urban fine particulate matter10.1021/acs.chemrev.5b00067 ↗
47. Health effects of ultrafine particles: a systematic literature review update of epidemiological evidence10.1007/s00038-019-01202-7 ↗
48. Bridging the gap between science and clinical efficacy: physiology, imaging, and modeling of aerosols in the lung10.1089/jamp.2015.1270 ↗
49. Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives10.1186/s12989-018-0282-0 ↗
50. An in vitro coculture system for the detection of sensitization following aerosol exposure
51. Diesel exhaust particle exposure reduces expression of the epithelial tight junction protein tricellulin10.1186/s12989-020-00383-x ↗
52. Lipophilic components of diesel exhaust particles induce pro-inflammatory responses in human endothelial cells through AhR dependent pathway(s)10.1186/s12989-018-0257-1 ↗
53. Analysis of carcinogenic polycyclic aromatic hydrocarbons in complex environmental mixtures by LC-APPI-MS/MS10.1016/j.aca.2011.07.003 ↗
54. Single-use porous thin film extraction with gas chromatography atmospheric pressure chemical ionization tandem mass spectrometry for high-throughput analysis of 16 PAHs10.1016/j.talanta.2019.120320 ↗